Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report Pharmaceutical Investing
New Data Show Abbott's HeartMate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients Pharmaceutical Investing
Gilead Demonstrates Strength of Oncology Portfolio Across Diverse Tumor Types at ESMO Congress 2022 Pharmaceutical Investing
AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology 2022 Congress Pharmaceutical Investing
Merck to Present New Data at ESMO 2022 Congress From Its Broad Oncology Portfolio and Promising Pipeline, Demonstrating Commitment to Improving Long-Term Survival in Multiple Types of Cancer Life Science Investing
Late-Breaking Results From Phase 2 AXIOMATIC-SSP Study of Milvexian, an Investigational Oral Factor XIa Inhibitor, Show Favorable Antithrombotic Profile in Combination With Dual Antiplatelet Therapy Pharmaceutical Investing
 Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine Life Science Investing
InvestmentPitch Media Video Discusses LOVE Pharma's Shareholders' Letter from CEO Zach Stadnyk Pharmaceutical Investing
LYNPARZA® Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer Life Science Investing
Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus Vaccine Candidate Life Science Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
